Daily Stock Ratings & Price Targets

Daily stock ratings from over 8,000 Wall Street analysts

Daily Buy Ratings

Analyst & Firm	Company	Rating & Price Target	Upside / Downside
Julien DormoisJefferies	CTEC ConvaTec	BUY300p	29.87% Upside
Nicolas PayenKepler Capital	NWG NatWest Group	BUY600p	17.28% Upside
Lushanthan MahendrarajahJ.P. Morgan	IMI IMI plc	BUY2,500p	14.89% Upside
Florent CespedesBernstein	GSK GlaxoSmithKline	BUY2,290p	63.98% Upside

Daily Sell Ratings

Analyst & Firm	Company	Rating & Price Target	Upside / Downside
Celine Pannuti CFAJ.P. Morgan	HLN Haleon PLC	SELL	―
Alexandre RaverdyKepler Capital	AML Aston Martin Lagonda Global Holdings plc	SELL60p	-10.51% Downside

Full List of Stock Ratings

(Aug 4, 2025)

Analyst Performance

Any

Analyst Rating

Any

Upside / Downside

Any

Action

Any

Market Cap

Any

Analyst & Firm	Company	Rating & Price Target	Upside / Downside	Average Return	Action	Date	Article
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 340.65p	―	7.80%	Reiterated	2025-08-03
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD 2,100p→2,200p	―	8.50%	Downgraded	2025-08-03
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 3,900p→4,450p	―	4.90%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 5,400p	―	1.70%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 350p→370p	―	11.00%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 2,720p	―	1.10%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 430p	―	2.40%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 4,000p	―	5.40%	Reiterated	2025-08-01
Emily FieldBarclays	GSK GlaxoSmithKline	HOLD 1,450p	―	-2.10%	Reiterated	2025-08-01	Barclays Sticks to Their Hold Rating for GlaxoSmithKline (GSK)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 550p	―	6.40%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD 11,950p→12,000p	―	12.30%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 1,100p→1,200p	―	3.60%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 5,350p→5,400p	―	2.40%	Reiterated	2025-08-01
Michelle Ma CFACiti	PRU Prudential	BUY 1,161p	―	-9.80%	Reiterated	2025-08-01	Citi Reaffirms Their Buy Rating on Prudential (PRU)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 112p	―	4.40%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 94p	―	4.40%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 13,620p→13,450p	―	1.80%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD 5,100p→5,400p	―	3.10%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 395p	―	11.60%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 440p	―	1.50%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 160p→170p	―	10.50%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD 2,450p→2,650p	―	15.20%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 1,650p→1,550p	―	11.00%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD 366p→400p	―	16.70%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD 83p→92p	―	10.30%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD 75p→77p	―	16.70%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 2,490p	―	5.60%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 400p	―	9.20%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 13,000p→12,500p	―	1.80%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL 4,000p→4,120p	―	0.80%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 2,950p→3,000p	―	3.40%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD 4,450p	―	4.80%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD 520p→550p	―	4.80%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 2,750p	―	22.30%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 13,100p	―	6.30%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 1,215p→1,446p	―	22.10%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD 1,285p	―	17.60%	Reiterated	2025-08-01
Sreedhar MahamkaliUBS	NXT Next plc	BUY 14,200p	―	-1.90%	Reiterated	2025-08-01	UBS Sticks to Its Buy Rating for Next plc (NXT)
Ed HusseyUBS	WEIR Weir Group plc (The)	BUY 2,850p	―	-1.10%	Reiterated	2025-08-01	UBS Sticks to Its Buy Rating for Weir Group plc (The) (WEIR)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 1,310p	―	2.50%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 810p	―	2.90%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 440p	―	6.30%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD 380p	―	1.80%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL 245p→250p	―	2.90%	Reiterated	2025-08-01
Priyanka PatelUBS	ELM Elementis	BUY 175p	―	-9.70%	Reiterated	2025-08-01	UBS Sticks to Their Buy Rating for Elementis (ELM)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 1,300p→1,200p	―	14.40%	Upgraded	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 12,700p→12,800p	―	7.40%	Reiterated	2025-08-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY 610p→595p	―	16.70%	Reiterated	2025-08-01
Rajan SharmaGoldman Sachs	GSK GlaxoSmithKline	HOLD 1,560p→1,550p	―	-3.50%	Reiterated	2025-08-01	Goldman Sachs Keeps Their Hold Rating on GlaxoSmithKline (GSK)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD 110p	―	10.00%	Downgraded	2025-08-01

Rows:

Ready for the Full Picture?Your current plan limits your access to top-tier analyst ratings. Subscribe to Premium now and unlock the full range of ratings from the highest-ranked analysts on Wall Street. Don't let partial views limit your market research potential - upgrade today!

Upgrade Now Plans & Pricing